logo

ITOS(Delisted)

iTeos TherapeuticsยทNASDAQ
--
--(--)

ITOS Profile

Iteos Therapeutics, Inc.

A clinical-stage biopharmaceutical company that developing immuno-oncology therapeutics for cancer

--
10/04/2019
07/24/2020
NASDAQ Stock Exchange
173
12-31
Common stock
321 Arsenal St , Watertown , MA 02472
--
ITeos Therapeutics, Inc. was incorporated under the laws of the State of Delaware on October 4, 2019. The company is a clinical-stage biopharmaceutical company that has pioneered the discovery and development of a new generation of highly differentiated immuno-oncology therapies for patients. The company uses their deep understanding of the tumor microenvironment and immunosuppressive pathways to design new drug candidates with the goal of improving the clinical efficacy of tumor therapy.